Eccleston J - Search Results

1

Some considerations on the design of population pharmacokinetic studies.

Duffull S, Waterhouse T, Eccleston J. Duffull S, et al. Among authors: eccleston j. J Pharmacokinet Pharmacodyn. 2005 Aug;32(3-4):441-57. doi: 10.1007/s10928-005-0034-2. J Pharmacokinet Pharmacodyn. 2005. PMID: 16284917

2

Optimal design criteria for discrimination and estimation in nonlinear models.

Waterhouse TH, Eccleston JA, Duffull SB. Waterhouse TH, et al. Among authors: eccleston ja. J Biopharm Stat. 2009;19(2):386-402. doi: 10.1080/10543400802677257. J Biopharm Stat. 2009. PMID: 19212887

3

Simultaneous versus sequential optimal design for pharmacokinetic-pharmacodynamic models with FO and FOCE considerations.

McGree JM, Eccleston JA, Duffull SB. McGree JM, et al. Among authors: eccleston ja. J Pharmacokinet Pharmacodyn. 2009 Apr;36(2):101-23. doi: 10.1007/s10928-009-9113-0. Epub 2009 Feb 18. J Pharmacokinet Pharmacodyn. 2009. PMID: 19224348

4

Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients.

Waterhouse TH, Redmann S, Duffull SB, Eccleston JA. Waterhouse TH, et al. J Pharmacokinet Pharmacodyn. 2005 Aug;32(3-4):521-45. doi: 10.1007/s10928-005-0026-2. J Pharmacokinet Pharmacodyn. 2005. PMID: 16307208 Clinical Trial.

5

Optimal crossover designs for logistic regression models in pharmacodynamics.

Waterhouse TH, Eccleston JA, Duffull SB. Waterhouse TH, et al. Among authors: eccleston ja. J Biopharm Stat. 2006;16(6):881-94. doi: 10.1080/10543400600851880. J Biopharm Stat. 2006. PMID: 17146986

6

Optimal designs for studying bioimpedance.

McGree JM, Duffull SB, Eccleston JA, Ward LC. McGree JM, et al. Among authors: eccleston ja. Physiol Meas. 2007 Dec;28(12):1465-83. doi: 10.1088/0967-3334/28/12/002. Epub 2007 Oct 31. Physiol Meas. 2007. PMID: 18057512

7

Compound optimal design criteria for nonlinear models.

McGree JM, Eccleston JA, Duffull SB. McGree JM, et al. Among authors: eccleston ja. J Biopharm Stat. 2008;18(4):646-61. doi: 10.1080/10543400802071352. J Biopharm Stat. 2008. PMID: 18607799

8

Evaluation of the pre-posterior distribution of optimized sampling times for the design of pharmacokinetic studies.

Duffull SB, Graham G, Mengersen K, Eccleston J. Duffull SB, et al. Among authors: eccleston j. J Biopharm Stat. 2012;22(1):16-29. doi: 10.1080/10543406.2010.500065. J Biopharm Stat. 2012. PMID: 22204524

9

Comparison of robust criteria for D-optimal designs.

Foo LK, McGree J, Eccleston J, Duffull S. Foo LK, et al. Among authors: eccleston j. J Biopharm Stat. 2012;22(6):1193-205. doi: 10.1080/10543406.2011.580484. J Biopharm Stat. 2012. PMID: 23075017

10

Estimation in a multiplicative mixed model involving a genetic relationship matrix.

Kelly AM, Cullis BR, Gilmour AR, Eccleston JA, Thompson R. Kelly AM, et al. Genet Sel Evol. 2009 Apr 9;41(1):33. doi: 10.1186/1297-9686-41-33. Genet Sel Evol. 2009. PMID: 19356255 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters